Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT02594059
Eligibility Criteria:
Inclusion Criteria:
* IPF according to ATS/ERS 2011's criteria
* Stable IPF (no reduction of FVC or DLCO of more than 10% and 15% respectively)
Exclusion Criteria:
* Patients with a significant disease other than IPF. A significant disease is defined as a disease which, in the opinion of the investigator, may influence the results of the trial.
* Pregnant or nursing women.
* Non-pulmonary fibrosis
* treatment by pulmonary vasodilators that cannot be stopped for 24 hours for the assessment of endothelial function
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02594059
Study Brief:
Protocol Section:
NCT02594059